Literature DB >> 4344024

Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells.

C L Larson, R N Ushijima, R Karim, M B Baker, R E Baker.   

Abstract

Angora, New Zealand, and Dutch-belted rabbits were tested for their susceptibility to graded doses of Herpesvirus hominis type 2 administered by vaginal instillation, intracorneal injection, and scarification of the cornea. Central nervous system involvement and death occurred after infection by the various routes employed. Prior immunization of Dutch-belted and New Zealand rabbits with viable Mycobacterium bovis (BCG) cells injected intravenously provided protection against subsequent infections with type 2 virus.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4344024      PMCID： PMC422560          DOI： 10.1128/iai.6.4.465-468.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  Genital herpetic infection. Association with cervical dysplasia and carcinoma.

Authors:  Z M Naib; A J Nahmias; W E Josey; J H Kramer
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

2.  "Treatment-resistance" to idoxuridine in herpetic keratitis.

Authors:  V R Coleman; E Tsu; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

Review 3.  Cellular immunity.

Authors:  G B Mackaness; R V Blanden
Journal:  Prog Allergy       Date:  1967

4.  Increased antibacterial resistance and immunodepression during graft-versus-host reactions in mice.

Authors:  R V Blanden
Journal:  Transplantation       Date:  1969-06       Impact factor: 4.939

5.  The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors:  W E Rawls; W A Tompkins; J L Melnick
Journal:  Am J Epidemiol       Date:  1969-05       Impact factor: 4.897

6.  Recall of immunity in mice vaccinated with Salmonella enteritidis or Salmonella typhimurium.

Authors:  F M Collins
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

7.  Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA.

Authors:  J H Park; S Baron
Journal:  Science       Date:  1968-11-15       Impact factor: 47.728

8.  Herpesvirus type 2: association with carcinoma of the cervix.

Authors:  W E Rawls; W A Tompkins; M E Figueroa; J L Melnick
Journal:  Science       Date:  1968-09-20       Impact factor: 47.728

9.  Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.

Authors:  W Brehmer; R L Anacker; E Ribi
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307
View more
  12 in total

1.  Herpes genitalis in guinea-pigs. I. Kinetic study in infection with Herpesvirus hominis type 2.

Authors:  B Lukás; W Wiesendanger; K H Schmidt-Ruppin
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Antiviral effect of pyran against systemic infection of mice with herpes simplex virus type 2.

Authors:  R S McCord; M K Breinig; P S Morahan
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Resistance to vaginal or systemic infection with herpes simplex virus type 2.

Authors:  M C Breinig; L L Wright; M B McGeorge; P S Morahan
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  The effect of BCG-vaccination on vaccinia virus infections in mice.

Authors:  G T Werner
Journal:  Experientia       Date:  1979-11-15

Review 6.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

7.  Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.

Authors:  N A Sher; S D Chaparas; L E Greenberg; S Bernard
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

8.  Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.

Authors:  T Sakuma; T Suenaga; I Yoshida; M Azuma
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

9.  Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.

Authors:  R Cappel; F de Cuyper; K De Neef; W Höbel; K Bolla
Journal:  Surv Immunol Res       Date:  1985

10.  Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.